IBDEI0HH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7869,2)
 ;;=^5009002
 ;;^UTILITY(U,$J,358.3,7870,0)
 ;;=L02.92^^39^391^158
 ;;^UTILITY(U,$J,358.3,7870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7870,1,3,0)
 ;;=3^Furuncle,Unspec
 ;;^UTILITY(U,$J,358.3,7870,1,4,0)
 ;;=4^L02.92
 ;;^UTILITY(U,$J,358.3,7870,2)
 ;;=^5009017
 ;;^UTILITY(U,$J,358.3,7871,0)
 ;;=L02.93^^39^391^94
 ;;^UTILITY(U,$J,358.3,7871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7871,1,3,0)
 ;;=3^Carbuncle,Unspec
 ;;^UTILITY(U,$J,358.3,7871,1,4,0)
 ;;=4^L02.93
 ;;^UTILITY(U,$J,358.3,7871,2)
 ;;=^5009018
 ;;^UTILITY(U,$J,358.3,7872,0)
 ;;=L03.011^^39^391^110
 ;;^UTILITY(U,$J,358.3,7872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7872,1,3,0)
 ;;=3^Cellulitis of Right Finger
 ;;^UTILITY(U,$J,358.3,7872,1,4,0)
 ;;=4^L03.011
 ;;^UTILITY(U,$J,358.3,7872,2)
 ;;=^5009019
 ;;^UTILITY(U,$J,358.3,7873,0)
 ;;=L03.012^^39^391^103
 ;;^UTILITY(U,$J,358.3,7873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7873,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,7873,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,7873,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,7874,0)
 ;;=L03.021^^39^391^25
 ;;^UTILITY(U,$J,358.3,7874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7874,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,7874,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,7874,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,7875,0)
 ;;=L03.022^^39^391^19
 ;;^UTILITY(U,$J,358.3,7875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7875,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,7875,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,7875,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,7876,0)
 ;;=L03.031^^39^391^113
 ;;^UTILITY(U,$J,358.3,7876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7876,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,7876,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,7876,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,7877,0)
 ;;=L03.032^^39^391^106
 ;;^UTILITY(U,$J,358.3,7877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7877,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,7877,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,7877,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,7878,0)
 ;;=L03.041^^39^391^27
 ;;^UTILITY(U,$J,358.3,7878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7878,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,7878,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,7878,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,7879,0)
 ;;=L03.042^^39^391^21
 ;;^UTILITY(U,$J,358.3,7879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7879,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,7879,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,7879,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,7880,0)
 ;;=M34.0^^39^391^289
 ;;^UTILITY(U,$J,358.3,7880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7880,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,7880,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,7880,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,7881,0)
 ;;=M34.1^^39^391^92
 ;;^UTILITY(U,$J,358.3,7881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7881,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,7881,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,7881,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,7882,0)
 ;;=M34.2^^39^391^313
 ;;^UTILITY(U,$J,358.3,7882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7882,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
